Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -1.792% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC12CCC(=O)N1C(C(=O)Nc1nc(-c3ccc(F)c(F)c3)cs1)CS2
b. COc1cc(NC(=O)c2ccccc2)c(OC)cc1NC(=O)CN1CCCCC1.Cl
c. Cc1ccc(CC2CC(=O)N(c3nc4ccccc4n3C)C2=O)cc1
Answer: c. Cc1ccc(CC2CC(=O)N(c3nc4ccccc4n3C)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CC2CC(=O)N(c3nc4ccccc4n3C)C2=O)cc1
Cc1ccc(CC2CC(=O)N(c3nc4ccccc4n3C)C2=O)cc1
1-(1-methylbenzimidazol-2-yl)-3-[(4-methylphenyl)methyl]pyrrolidine-2,5-dione